UMass Chan Participates in National TMIST Study

Gopal Vijayaraghavan, MD, Division Chief Breast Imaging, is the principal investigator for TMIST.

Our Medical Center is participating alongside 100 mammography clinics across the United States and Canada in a clinical trial called TMIST (Tomosynthesis Mammographic Imaging Screening Trial) to determine if 3D mammography is better than 2D mammography for breast cancer screening. Unlike 2D screening, 3D screening uses tomosynthesis, which takes images from several different angles around the breast to generate the 3D image. Gopal Vijayaraghavan, MD, director of the division of breast imaging, said, “It’s hoped that based on mammography morphology, we’ll be able to identify tumors that are more aggressive and tailor treatment accordingly.” Learn more in the UMass Memorial Health Care 2017 Annual Report of Cancer Services